Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
Stability of Oral Oxytocics in Tropical Climates - Results of Simulation Studies on Oral Ergometrine, Oral Methylergometrine, Buccal Oxytocin and Buccal Desamino-Oxytocin - EDM Research Series No. 012
(1994; 52 pages) Voir le document au format PDF
Table des matières
Afficher le documentAbbreviations
Afficher le documentSummary
Ouvrir ce répertoire et afficher son contenuIntroduction
Ouvrir ce répertoire et afficher son contenuMaterials and methods
Ouvrir ce répertoire et afficher son contenuResults
Ouvrir ce répertoire et afficher son contenuDiscussion
Afficher le documentConclusions and recommendations
Afficher le documentReferences
Ouvrir ce répertoire et afficher son contenuAnnexes



This study is part of a research programme that aims to reduce postpartum haemorrhage (PPH). The use of oral oxytocics, with their positive effects on blood loss and maternal morbidity and mortality, was regarded as a possible means of reducing PPH in tropical countries. It is known that injectable oxytocin is more stable than injectable ergometrine and methylergometrine, but the stability of oral oxytocics under tropical conditions is unknown, and is the subject of this study. Four oral oxytocics were included: ergometrine tablets (E), methylergometrine coated tablets (ME), buccal oxytocin (OT) and buccal desamino-oxytocin (DOT).

Study methods

The stability of oral oxytocics in tropical climates was examined by exposing the tablets to seven artificially regulated conditions. Temperatures ranged between 6-40°C and relative humidity (RH) between 20-85% in the dark, with ambient temperatures used under exposure to daylight. At nine different times during a period of one year, samples were taken and analysed on the content of active ingredients using High Performance Liquid Chromatography (HPLC).


Ergometrine and methylergometrine

After refrigerated storage of 14 and 21 weeks respectively, E and ME had less than 90% of the stated amount of active ingredient. In the dark at 40°C/75% RH the level fell below 90% within 3 and 21 weeks respectively. Stability of uncoated E-tablets was slightly less than that of the coated ME but for both instability increased with humidity and temperature. From week 31 onwards the coating no longer seemed to protect the stability of ME.

Oxytocin and desamino-oxytocin

Under refrigerated storage OT and DOT were slightly more stable then E and ME. Under humid conditions, the level of active ingredient in both drugs fell below 90% after 20 weeks, independent of temperature. DOT was more sensitive to light than OT (after one year’s exposure to light, 60% and 75% of active ingredient respectively remained). For 21 weeks the level of active ingredient in OT remained above 90% at 75% RH at 30 and 40°C. At 40°C/25% RH no difference in stability was noted between the tablets packed in a sealed aluminium package by the manufacturer, and unpacked tablets directly exposed to the defined test condition.


None of the oral oxytocics included in this study were stable under simulated tropical conditions. Oral ergometrine was the least stable under all simulated conditions. It is unlikely that oral oxytocics can be effective in the prevention of PPH in tropical climates.


vers la section précédente
vers la section suivante
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019